General description
Moxifloxacin is an antibiotic used as second line treatment for multi-drug resistant tuberculosis (MDR-TB).
INN
Moxifloxacin
Medicine type
Chemical agent
EML status history
First added in 2017
(TRS
1006)
for
Multi-drug resistant tuberculous Mycobacterium
Therapeutic equivalent for
Wikipedia
DrugBank
Recommendations
Section
Antituberculosis medicines
- Oral > Solid: 400 mg tablet; 100 mg tablet (dispersible)
Indications